Key facts
- CorVent Medical’s last known valuation is $40.5M (Jun 2025).
- It has raised $77.9M across 2 recorded rounds; the latest was Seed Round ($3.8M) in Dec 2024.
- Notable investors include Sofinnova Partners, EXOR Seeds, Redmile Group, PagsGroup, Genesis Medtech — 9 tracked in total.
- CorVent Medical has filed 3 Form Ds with the SEC since 2024, most recently Jun 2025 ($3.8M sold to 4 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for CorVent Medical
Funding rounds
2 roundsAbout CorVent Medical
Developer of ventilators and respiratory products designed to support acute, sub-acute, and home use. The company's products utilize the latest technologies to provide cost-effective and connected solutions for healthcare providers, staff, and patients, enabling hospitals, states, and countries to cost-effectively and efficiently address respiratory insufficiency, so healthcare providers can immediately focus on critical patient needs.
- Sector
- Healthcare
- HQ
- Fargo, ND, United States
- Founded
- 2020
- Employees
- 40
- Website
- corventmedical.com/
- Ownership
- Privately Held (backing)
CorVent Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CorVent Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CorVent Medical in its N-PORT filings yet. We sweep new filings monthly.